Paper · 84015
Biochemical relationship between murine immune interferon and a killer cell helper factor.
Simon PL and 2 others. J Immunol, 1979. Cited by 87 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Biochemical relationship between murine immune interferon and a killer cell helper factor. Papers, record 84015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/84015
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biochemical relationship between murine immune interferon and a killer cell helper factor.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Killer Cells, Natural | Major topic |
| T-Lymphocytes | Major topic |
| Ammonium Sulfate | |
| Animals | |
| Chromatography | |
| Chromatography, Gel | |
| Epitopes | |
| Female | |
| Hydrogen-Ion Concentration | |
| Hydroxyapatites | |
| Male | |
| Mice | |
| Mice, Inbred AKR | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,263,014 | A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusions. | J Cancer Res Clin Oncol | 1994 | https://conductscience.org/library/papers/8263014 | PubMed |
| 6,813,857 | Production of immune interferon by an interleukin 2-independent murine T cell line. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6813857 | PubMed |
| 6,785,748 | T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6785748 | PubMed |
| 6,781,356 | Theileriosis: cell-mediated and humoral immunity. | Am J Pathol | 1981 | https://conductscience.org/library/papers/6781356 | PubMed |
| 6,609,885 | Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae. | Infect Immun | 1984 | https://conductscience.org/library/papers/6609885 | PubMed |
| 6,609,400 | Therapeutic use of interleukins: experimental results. | Surv Immunol Res | 1984 | https://conductscience.org/library/papers/6609400 | PubMed |
| 6,451,236 | In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6451236 | PubMed |
| 6,334,553 | Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6334553 | PubMed |
| 6,217,274 | Helper cells in the autologous mixed lymphocyte reaction. III. Production of helper factor(s) distinct from interleukin 2. | J Exp Med | 1982 | https://conductscience.org/library/papers/6217274 | PubMed |
| 3,155,703 | Immunoregulation by mouse T-cell clones. II. The same H-Y-specific T helper clone can provide help for the generation of cytotoxic lymphocytes and antibody-secreting cells. | Immunology | 1985 | https://conductscience.org/library/papers/3155703 | PubMed |
1 to 10 of 15
See all 15 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/84015
GET https://conductscience.org/api/papers/v1/84015/authors